Skip to main content
Veterinary Medicines

Parpumag 30% Solution injectable

Authorised
  • Magnesium chloride hexahydrate
  • Calcium gluconate

Product identification

Medicine name:
Parpumag 30% Solution injectable
Parpumag 30% Injektionslösung
Active substance:
  • Magnesium chloride hexahydrate
  • Calcium gluconate
Target species:
  • Sheep
  • Cattle
  • Horse
  • Pig
Route of administration:
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Magnesium chloride hexahydrate
    33.30
    milligram(s)
    /
    1.00
    millilitre(s)
  • Calcium gluconate
    298.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Sheep
      • Meat and offal, milk
        no withdrawal period
    • Cattle
      • Meat and offal, milk
        no withdrawal period
    • Horse
      • Meat and offal, milk
        no withdrawal period
    • Pig
      • Meat and offal
        no withdrawal period
  • Subcutaneous use
    • Cattle
      • Meat and offal, milk
        no withdrawal period
    • Sheep
      • Meat and offal, milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA02AD
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Package description:
  • Parpumag 450 ml Vial Solution for injection
  • Parpumag 500 ml Vial Solution for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Dechra Veterinary Products
Marketing authorisation date:
Manufacturing sites for batch release:
  • Eurovet Animal Health B.V.
Responsible authority:
  • Le Ministère De La Santé Division De La Pharmacie Et Des Médicaments
Authorisation number:
  • V 855/15/06/1448
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 12/12/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."